Rebalix
Logo InvescoInvesco · sheet of 4 September 2026
ETF sheet · official issuer and register data

Invesco US Treasury Bond UCITS ETF Dist

TRES · IE00BF2GFH28 · class Dist · USD · domicile Ireland
Bonds · Government · Broad (all maturities) · North AmericaSFDR art. 6
Index tracked: Bloomberg US Treasury Index
TER
0.06%+ trans. 0.00%
Fund size
561 m EUR
Tracking difference
−0.01%3-year avg
🇮🇹 tax rate
12.50%white list 100.00%
Replication
Physical
Income
Distributingquarterly
Duration
5.51 yrsmedium (3–7 years)
Launch 11 Jan 2019 · costs from the KID as of 14 Aug 2026 · 300 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Redemption and Dealing of Shares: The Fund's shares are listed on one or more Stock Exchange(s). Investors can buy or sell shares daily through an intermediary directly or on Stock Exchange(s) on which the shares are traded. In exceptional circumstances investors will be permitted to redeem their shares directly from the Umbrella Fund in accordance with the redemption procedures set out in the prospectus, subject to any applicable laws and relevant charges. Investment objective: The objective of the Fund is to aim to track the Total Return performance of…

Performance since series start (in euro) — base 100

11 Jan 20191 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2020202120222023202420252026125100108
High 125 (23 Apr 2020) · low 100 (11 Jan 2019) · last 108. Past performance is not indicative of future results.

Returns in euro

1 year+1.6%
3 years+3.0%
5 years−2.2%
10 yearsseries too young
Since series start+8.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)3.95%5.13%5.92%
Max drawdown−4.55%−6.69%−20.63%
Sharpe-1.33-0.74-1.10
Sortino-1.65-0.97-1.46
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · TRES · IE00BF2GFH281
RebalixTRES · IE00BF2GFH28 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+6.31%+6.32%−0.01%
2024+0.59%+0.58%+0.01%
2023+4.02%+4.05%−0.03%
2022−12.48%−12.46%−0.02%
2021−2.34%−2.32%−0.01%

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.5%
Rating breakdown (% of fund)
AA99.5%Cash and derivatives0.5%
Maturity breakdown (% of fund)
9 to 12 months1.3%1 to 3 years34.0%3 to 5 years22.1%5 to 10 years21.7%10 to 20 years9.4%20+ years11.0%Cash and derivatives0.5%

Distributions · per share, in USD

Frequency: quarterly · last 12 months: 1.5279 USD (4.31% of NAV) · last ex-date 10 Sept 2026
YearPaymentsTotal (USD)Dividend yield
202631.1526
202541.5307+4.29%
202441.5218+4.11%
202341.3957+3.78%
202240.724+1.68%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 300 securities · top-10 weight = 8.1%
Countries (% of fund)
United States100.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
TRES · Borsa Italiana (ETFplus)
TRDS · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE00BF2GFH28
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · TRES · IE00BF2GFH282